Increased levels of high-density lipoprotein cholesterol are ineffective in inhibiting the development of immune responses to oxidized low-density lipoprotein and atherosclerosis in transgenic rabbits expressing human apolipoprotein (apo) A-I with severe hypercholesterolaemia

Clinical Science

Volumn 100, Issue 3, 2001, Pages 343-355

  Boullier, A ^a   Hennuyer, N ^a   Tailleux, A ^a   Furman, C ^a   Duverger, N ^a   Caillaud, J M ^a   Castro, G ^a   Fievet, C ^a   Fruchart, J C ^a   Duriez, P ^a  

^a INSTITUT PASTEUR DE LILLE   (France)

Author keywords

Anti (oxidized LDL) autoantibodies; Anti cardiolipin autoantibodies; Apolipoprotein A I; Atherosclerosis; IgG bound LDL; Paraoxonase; Rabbit; Transgenesis

Indexed keywords

APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA ATHEROSCLEROSIS; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; HYPERCHOLESTEROLEMIA; IMMUNE RESPONSE; LIPID OXIDATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTIBODIES, ANTICARDIOLIPIN; APOLIPOPROTEIN A-I; ARTERIOSCLEROSIS; AUTOANTIBODIES; BIOLOGICAL MARKERS; CHOLESTEROL, HDL; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; LIPOPROTEINS, LDL; MALE; OXIDATION-REDUCTION; RABBITS; STATISTICS, NONPARAMETRIC;

EID: 17744373154     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20000213     Document Type: Article

References (55)

1. Oxidized lipoproteins and atherosclerosis
2. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein
3. Autoantibodies against oxidised LDL and progression of carotid atherosclerosis
4. Isolation and characterization of human antioxidized LDL autoantibodies
5. Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis
6. Rabbit and human atherosclerotic lesions contain IgG that recognize epitopes of oxidized LDL
7. Immunoglobulin-bound lipoproteins (Ig-Lp) as markers of familial hypercholesterolemia, xanthomatosis and atherosclerosis
8. Correlation between cholesterol content in circulating immune complexes and atherogenic properties of CHD patients' serum manifested in cell culture
9. Characteristics of low density lipoprotein isolated from circulating immune complexes
10. Anticardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men
11. Crossreaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus
12. Affinity-purified cardiolipin-binding antibodies show heterogeneity in their binding to oxidized low-density lipoprotein
13. Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein
14. High-density lipoprotein cholesterol and coronary heart disease in hypercholesterolemic men: The Lipid Research Clinics Coronary Primary Prevention Trial
15. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein A-I
16. Comparative analysis of mammalian plasma lipoproteins
17. Hyperlipoproteinemia and atherosclerosis in rabbits fed low-level cholesterol and lecithin
18. Transgenic rabbits expressing human apolipoprotein A-I in the liver
19. Inhibition of atherosclerosis development in cholesterol-fed human apolipoprotein A-I-transgenic rabbits
20. Protective effect of lipoproteins containing apolipoprotein A-I on Cu2+-catalyzed oxidation of human low density llpoprotein
21. Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein
22. HDL antioxidant effects as assessed using a nonexchangeable probe to monitor particle-specific peroxidative stress in LDL-HDL mixtures
23. Human serum paraoxonase/arylesterase
24. Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus
25. Is paraoxonase related to atherosclerosis?
26. Possible medical significance of human serum 'A' esterases
27. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein
28. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis
29. Combined serum paraoxonase knockout/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis
30. HDL apolipoprotein A-I attenuates oxidative modification of low density lipoprotein: Studies in transgenic mice
31. Paraoxonase activity is reduced by a pro-atherogenic diet in rabbits
32. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum
33. Protein measurement with the folin phenol reagent
34. Biochemical, structural, and functional properties of oxidized low density lipoprotein
35. Assay for lipid peroxides in animal tissues by TBA reaction
36. A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent
37. The role of lipid peroxidation and antioxidants in oxidative modification of low density lipoprotein
38. Decrease in reactive amino groups during oxidation or endothelial cell modification of low density lipoprotein: Correlation with changes in receptor mediated catabolism
39. Endothelial derived vasorelaxation is impaired in human apo A-I transgenic rabbits
40. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans
41. Increased susceptibility to lipid oxidation of low-density lipoproteins and erythrocyte membranes from diabetic patients
42. Impairment of endothelium-dependent dilatation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein (a) level
43. Chronic selective hypertriglyceridemia impairs endothelium dependent vasodilatation in rats
44. Endothelium-dependent relaxation by acetylcholine is impaired in hypertriglyceridemic humans with normal levels of plasma LDL cholesterol
45. Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbits
46. Dietary arginine prevents atherogenesis in the coronary artery of the hypercholesterolemic rabbit
47. Impairment of endothelium-dependent arterial relaxation by lysolecithine modified-low-density lipoproteins
48. Lysophosphatidylcholine: Essential role in the inhibition of endothelium-dependent vasorelaxation by oxidized low density lipoprotein
49. Localization of oxidized HDL in atheromatous plaques and oxidized HDL binding sites on human aortic endothelial cells
50. Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic disease
51. Apo E-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum
52. Evidence for the in vivo generation of oxidatively modified epitopes in patients with atherosclerotic endothelium
53. Autoantibodies against oxidized low-density lipoprotein and cardiolipin in patients with coronary heart disease
54. Detection of autoantibodies against oxidized low-density lipoproteins and IgG-bound low density lipoproteins in patients with coronary artery disease